thanx Patches for the information. Not all my money is in

New Post Public Reply Private Reply Replies (0) Message Board
Freewayflyer patches #48114
568
thanx Patches for the information. Not all my money is in RMHB just most of it I have money in ACOL & ALKM & VTNL. Those stock have some potential but they are all related to the CBD oil business. The problem with them as with RMHB is that they all have billions is outstanding shares.But my pps. is real low. but I'm holding on long & strong GLTA

Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links

RMHB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Québecor Makes Its Move: Eye on TELUS Amid Telecom Shakeup

Updated Category News Views 142

The Offer That Shocked the Telecom Markets Just when you think you’ve figured out the lay of the land, someone throws a curveball. Québecor’s decision to take a run at TELUS is shaking up Canada’s telecom scene big time. This isn’t just another M&A whisper; it’s a roaring freight train of a proposal valued at a whopping $31 billion. And TELUS, not just sitting...

Continue Reading
Cheyenne Real Estate: Neighborhood Nuances and Choices

Updated Category News Views 156

Unearthing the Hidden Dynamics of Cheyenne's Real Estate You've got this picturesque vision in your head of Cheyenne, Wyoming—a sprawling cowboy town with its wild winds and wide-open spaces. But if you think all those neighborhoods are cut from the same cloth, you've got another thing coming. The real estate scene here is just as varied as the prairies stretching out...

Continue Reading
NVIDIA Faces Fraud Suit: Investors Called to Action

Updated Category News Views 65

NVIDIA and the Quest for Accountability Nothing screams chaos in the market louder than a securities fraud lawsuit hitting the headlines. Investors currently eyeballing NVIDIA Corporation (NASDAQ: NVDA) are in for a wild ride. Yep, you heard it right—NVIDIA is smack in the middle of a class action lawsuit. They're being accused of misleading the market about some shady...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 194

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading
Kos & FORTH Partner to Spark Greek Biotech Growth

Updated Category News Views 81

New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...

Continue Reading
Painter's Accessory Aims to Revolutionize Convenience

Updated Category News Views 89

Crafty New Invention Targets Painters' Ease Ever find yourself tangled in paintbrushes and rollers while trying to get that perfect coat on the wall? Well, a painter from Bracebridge, Ontario, has had it with the struggle and is looking to stir the pot with their latest invention, the NU LIFE LINER. It's sleek, it's practical, and it's aimed at flipping the painting game...

Continue Reading
Intel Faces Class Action Over Alleged Securities Fraud

Updated Category News Views 122

Intel's Legal Predicament: Decoding the Lawsuit Saddle up, folks, because Intel (NASDAQ: INTC) has found itself tangled in legal vines again. This ain't their first rodeo, and probably won't be their last. We're looking at a hefty class action lawsuit rallying on claims that Intel misled investors with optimistic yarns about their health. SBS Law, waving the litigation...

Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 292

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
NeuroPace Faces Investigation After Revenue Forecast Cut

Updated Category News Views 35

NeuroPace Revenue Drama: A Blow to Investor Confidence How the mighty have stumbled—or so it feels to the folks who put their bucks into NeuroPace, Inc. (NASDAQ: NPCE). It's tough to swallow: they cut their 2026 revenue forecast from a hopeful $99.5-$101.5 million to a sobering $91-$92 million. Just one quarter apart those projections are, like a cruel twist of fate...

Continue Reading
GALC Launches Tender Offer on 2027 Notes Amid Debt Play

Updated Category News Views 70

Aviation Leasing Giant's Strategic Financial Move Well folks, we're staring down the barrel of a financial maneuver by Global Aircraft Leasing Co., Ltd. (GALC) that’s not just another day at the office. They've kicked off a cash tender offer for their 8.750% Senior Secured Notes due 2027, aiming to sweep up any and all outstanding ones. That's $932 million in principle...

Continue Reading

Top 5 Most Recently Viewed Articles

GIGABYTE Unveils Compact NVIDIA GeForce RTX 50 Series GPUs

Updated Category News Views 348

GIGABYTE Shines at CES with Revolutionary Graphics Card Launch The latest unveiling from GIGABYTE, a leader in innovative computer hardware, features their NVIDIA GeForce RTX™ 50 Series graphics cards. These models, including the GeForce RTX™ 5090, RTX™ 5090 D, RTX™ 5080, RTX™ 5070 Ti, and RTX™ 5070, promise to elevate gaming and creative experiences...

Continue Reading
EssilorLuxottica's Strategic Share Buyback Announcement Details

Updated Category News Views 246

EssilorLuxottica: Share Buyback Update Disclosure of transactions in own shares EssilorLuxottica has recently informed the public about its share buyback activities, following the authorization from its Annual Shareholders’ Meeting held on April 30, 2024. This initiative reflects the company's commitment to maintaining a healthy and robust stock market presence. Recent...

Continue Reading
Aker BP Announces Ex-Dividend Payment of USD 0.63 Today

Updated Category News Views 185

Understanding Aker BP's Ex-Dividend Payment Aker BP ASA has officially announced that its shares will commence trading ex-dividend today, marking a significant moment for investors. The ex-dividend amount is set at USD 0.63 per share, equivalent to NOK 6.36193. This announcement is crucial for shareholders looking to understand their financial returns from this reputable...

Continue Reading
PL Developments Secures FDA Nod for Omeprazole and Debt Restructure

Updated Category News Views 331

PL Developments Reaches Major Milestones With FDA Approval PL Developments (PLD), a leader in the healthcare sector, recently announced two substantial achievements: the FDA's approval for its Omeprazole OTC ANDA and the successful refinancing of its corporate debt. These milestones mark significant advancements in the company's ongoing efforts to innovate and grow....

Continue Reading
Akari Therapeutics Gears Up for Innovations in ADC Payloads

Updated Category News Views 237

Akari Therapeutics Gears Up for Innovations in ADC Payloads Akari Therapeutics, Plc (NASDAQ: AKTX), is making strides in the oncology biotechnology field, particularly with its progressive advancements in antibody drug conjugates (ADCs). Recently, the company released an insightful segment of the CEO Corner, which provides a comprehensive update on its initiatives and...

Continue Reading